» Articles » PMID: 37334132

The Link Between Lymphocyte Subpopulations in Peripheral Blood and Metabolic Variables in Patients with Severe Obesity

Abstract

Background: Obesity, a public health problem, is a state of metainflammation that influences the development of chronic degenerative diseases, particularly in patients with severe obesity.

Objective: The objective of this study was to evidence immunometabolic differences in patients with different degrees of obesity, including severe obesity, by determining correlations between lymphocyte subpopulations and metabolic, body composition, and clinical variables.

Methods: Peripheral blood immune cells (CD4+, CD8+ memory and effector T lymphocytes) were analyzed, and measures of body composition, blood pressure, and biochemical composition (glucose, glycated hemoglobin (HbA1c), insulin, C-reactive protein (CRP), and the lipid profile) were carried out in patients with different degrees of obesity.

Results: The patients were classified according to total body fat (TBF) percentage as normal body fat, class 1 and 2 obesity, class 3 obesity, and class 4 obesity. The greater the TBF percentage, the more pronounced the differences in body composition (such as a decrease in the fat-free mass (FFM) that is defined as sarcopenic obesity) and the immunometabolic profile. There was an increase of CD3+ T lymphocytes (mainly CD4+, CD4+CD62-, and CD8+CD45RO+ T lymphocytes) and an increase in the TBF percentage (severity of obesity).

Conclusions: The correlations between lymphocyte subpopulations and metabolic, body composition, and clinical variables demonstrated the existence of a chronic, low-intensity inflammatory process in obesity. Therefore, measuring the immunometabolic profile by means of lymphocyte subpopulations in patients with severe obesity could be useful to determine the severity of the disease and the increased risk of presenting obesity-associated chronic degenerative diseases.

Citing Articles

Immunometabolic Changes Following Gastric Bypass and Sleeve Gastrectomy: A Comparative Study.

Rivera-Carranza T, Azaola-Espinosa A, Bojalil-Parra R, Zuniga-Leon E, Leon-Tellez-Giron A, Rojano-Rodriguez M Obes Surg. 2025; 35(2):481-495.

PMID: 39794663 PMC: 11836204. DOI: 10.1007/s11695-024-07598-3.


Characterizing Human Peripheral Blood Lymphocyte Phenotypes and Their Correlations with Body Composition in Normal-Weight, Overweight, and Obese Healthy Young Adults.

Kosovski I, Ciurea C, Ghiga D, Ciurea N, Hutanu A, Gliga F Medicina (Kaunas). 2024; 60(9).

PMID: 39336564 PMC: 11433724. DOI: 10.3390/medicina60091523.


T cells in obesity-associated inflammation: The devil is in the details.

Valentine Y, Nikolajczyk B Immunol Rev. 2024; 324(1):25-41.

PMID: 38767210 PMC: 11694249. DOI: 10.1111/imr.13354.


Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.

Pan H, Liu B, Luo X, Shen X, Sun J, Zhang A Lipids Health Dis. 2023; 22(1):205.

PMID: 38007441 PMC: 10675849. DOI: 10.1186/s12944-023-01966-1.

References
1.
Rosales Ricardo Y . [Anthropometry in the diagnosis of obese patients: a review]. Nutr Hosp. 2013; 27(6):1803-9. DOI: 10.3305/nh.2012.27.6.6044. View

2.
Zatterale F, Longo M, Naderi J, Raciti G, Desiderio A, Miele C . Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020; 10:1607. PMC: 7000657. DOI: 10.3389/fphys.2019.01607. View

3.
Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M . CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009; 15(8):914-20. DOI: 10.1038/nm.1964. View

4.
Liu R, Pugh G, Tevonian E, Thompson K, Lauffenburger D, Kern P . Regulatory T Cells Control Effector T Cell Inflammation in Human Prediabetes. Diabetes. 2021; 71(2):264-274. PMC: 8914282. DOI: 10.2337/db21-0659. View

5.
Touch S, Clement K, Andre S . T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes. Curr Diab Rep. 2017; 17(9):81. DOI: 10.1007/s11892-017-0900-5. View